Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Olaparib manufacturers

6 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

6 products found

olaparib

Tablets 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Comments
Dossier availability date: Q2 2026
Manufacturer #6978
This global pharmaceutical company specializes in branded and generic medications, offering a wide range of products across various therapeutic areas including dermatology, oncology, and respiratory therapy. They prioritize quality manufacturing with GMP certifications and hold several patents for their innovative drug formulations. The company boasts a strong global presence spanning North America, Europe, Asia, Africa, Latin America, and the Middle East, with multiple manufacturing facilities strategically located in key regions. Their commitment to research and development is evident through dedicated R&D centers focused on advancing therapies and improving patient care worldwide.

Manufacturer usually replies in 7 days

olaparib

Tablets, immediate release (IR) 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA, Canada
Comments
Dossier availability: North America, Canada, Europe, United Kingdom, Latin America, Emerging Market
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 11 days

olaparib

Tablets, immediate release (IR) 100 mg, 150 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA, Canada
Comments
Dossier availability: North America, Canada, Europe, United Kingdom, Latin America, Emerging Market
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 11 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible